Purchase Short-Term Access
Responding to the Rofecoxib Withdrawal Crisis: A New Model for Notifying Patients at Risk and Their Health Care Providers
Anil Jain, MD; Ashish Atreja, MD, MPH; C. Martin Harris, MD, MBA; Meghan Lehmann, PharmD; Jon Burns, BS; James Young, MD
Annals of Internal Medicine 2005;142:182-186.
doi:10.7326/0003-4819-142-3-200502010-00008
Purchase Online access to this article for 24 hours
